WALDENSTROM MACROGLOBULINEMIA Meaning and
Definition
-
Waldenstrom Macroglobulinemia, also known as lymphoplasmacytic lymphoma, is a rare type of non-Hodgkin lymphoma characterized by the excessive production of abnormal proteins called macroglobulins by bone marrow plasma cells. It is named after Jan G. Waldenstrom, the Swedish physician who first described the condition in 1944.
This condition arises when abnormal plasma cells start to multiply uncontrollably within the bone marrow, causing the overproduction and accumulation of macroglobulins in the blood. Macroglobulins are large immunoglobulin M (IgM) antibodies that do not function properly, leading to disturbances in the normal functioning of the immune system.
The excess macroglobulins can cause thickening of the blood, resulting in various symptoms such as fatigue, weakness, bleeding, vision problems, and enlarged lymph nodes, spleen, or liver. Additionally, patients may experience complications related to the accumulation of macroglobulins in organs such as the kidneys or lungs.
The exact cause of Waldenstrom Macroglobulinemia remains unknown, but genetic abnormalities and certain mutations have been associated with an increased risk of developing the condition. It predominantly affects older adults, typically diagnosed around the age of 60 or older.
Treatment options for Waldenstrom Macroglobulinemia may involve a combination of chemotherapy, targeted therapies, immunomodulatory drugs, and plasma exchange to reduce the levels of macroglobulins. Stem cell transplantation can also be explored for eligible patients. Although it is considered an incurable disease, Waldenstrom Macroglobulinemia is often manageable, with treatments aimed at controlling symptoms and slowing the progression of the condition.
Common Misspellings for WALDENSTROM MACROGLOBULINEMIA
- qaldenstrom macroglobulinemia
- aaldenstrom macroglobulinemia
- saldenstrom macroglobulinemia
- ealdenstrom macroglobulinemia
- 3aldenstrom macroglobulinemia
- 2aldenstrom macroglobulinemia
- wzldenstrom macroglobulinemia
- wsldenstrom macroglobulinemia
- wwldenstrom macroglobulinemia
- wqldenstrom macroglobulinemia
- wakdenstrom macroglobulinemia
- wapdenstrom macroglobulinemia
- waodenstrom macroglobulinemia
- walsenstrom macroglobulinemia
- walxenstrom macroglobulinemia
- walcenstrom macroglobulinemia
- walfenstrom macroglobulinemia
- walrenstrom macroglobulinemia
- waleenstrom macroglobulinemia
- waldwnstrom macroglobulinemia
Etymology of WALDENSTROM MACROGLOBULINEMIA
The word "Waldenstrom Macroglobulinemia" is named after two individuals who made significant contributions to its understanding and diagnosis.
1. Jan Gosta Waldenström (1906-1996) was a Swedish physician and hematologist who first described the disease in 1944. He noticed a group of patients with symptoms resembling lymphoma but with distinctive features, leading to the identification of a previously unrecognized disorder. Waldenström published the first comprehensive study on this condition and its characteristics.
2. Macroglobulinemia refers to the increased levels of macroglobulins, a type of immunoglobulin (antibody) protein, in the blood. This term was added to the name of the disease to further describe the primary feature seen in affected individuals.
Therefore, the term "Waldenstrom Macroglobulinemia" is a combination of Dr.
